Streetbeat News

Equity Actions

THAR

Tharimmune, Inc. (NASDAQ:THAR) announced a 1-for-15 reverse stock split, effective after market close on May 24, 2024. The stock will trade on a post-split basis starting May 28, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 3:13 pm

BOW

Bowhead Specialty Holdings Inc (NYSE:BOW) is set to IPO on May 23 on the NYSE, with shares priced between $14.00 and $16.00. The insider lock-up period will end on November 19, 2024.

Portfolio Pulse from Benzinga Insights

May 22, 2024 | 3:00 pm

KDLY

KindlyMD (NASDAQ:KDLY) is set to IPO on May 23, 2023, with shares priced at $5.50 each. The company focuses on holistic pain management and reducing opioid use.

Portfolio Pulse from Benzinga Insights

May 22, 2024 | 3:00 pm

AMC

GME

AMC Entertainment Holdings Inc (NYSE:AMC) shares are trading lower after Delaware's highest court upheld the company's APE stock conversion. The court's decision allows AMC to proceed with converting its AMC Preferred Equity units into common shares, a move initially met with shareholder concerns about dilution. The stock has been volatile recently due to renewed interest in meme stocks, partly driven by the return of 'Roaring Kitty' on social media. AMC has also raised $250 million in new equity capital and will hold its annual shareholder meeting on June 5.

Portfolio Pulse from Adam Eckert

May 22, 2024 | 2:57 pm

SNPS

Synopsys, Inc. (NASDAQ:SNPS) is set to release its Q2 earnings after the closing bell on Wednesday. Analysts expect earnings of $3.05 per share and revenue of $1.51 billion. The company recently agreed to sell its Software Integrity Group business. Analysts have reiterated Buy ratings with price targets ranging from $615 to $660.

Portfolio Pulse from Avi Kapoor

May 22, 2024 | 2:55 pm

KBDC

Kayne Anderson BDC's IPO shares opened for trade at $16.25 per share, below the IPO price of $16.63 per share on 6 million shares.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 2:22 pm

VIPS

Vipshop Holdings Limited (NYSE: VIPS) reported Q1 revenue of $3.83 billion, missing estimates of $3.93 billion. Despite the miss, gross margin increased to 23.7%, and adjusted earnings per ADS beat expectations at 65 cents. The company plans to repurchase $500 million worth of stock by the end of 2024. VIPS shares rose 4.5% to $17.19.

Portfolio Pulse from Nabaparna Bhattacharya

May 22, 2024 | 1:46 pm

RPD

On May 21, 2024, Rapid7's 13G filing revealed that Point72 Asset Management, L.P. has acquired a 5% stake in the company as of May 20, 2024.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 1:37 pm

BDRX

Biodexa Pharmaceuticals (NASDAQ: BDRX) shares are down 36% after the company announced $7 million in gross proceeds from warrant exercises. The warrants were exercised at a reduced price of $1.50 per ADS, and new unregistered warrants were issued. The proceeds will be used for advancing clinical stage assets and general corporate purposes. This follows a significant rally due to positive Phase 2 clinical trial results for eRapa.

Portfolio Pulse from Adam Eckert

May 22, 2024 | 1:32 pm

AMC

The Delaware High Court has upheld the conversion of AMC's APE stock, a significant legal decision for the company.

Portfolio Pulse from Benzinga Newsdesk

May 22, 2024 | 1:27 pm